5 years ago, we have started developing Alleye with the idea to reduce in-person ophthalmology appointments. In the new reality of Covid19, healthcare technologies like ours are becoming the way forward.
#telemedicine#ophthalmology#digitalhealth
https://t.co/bC17AoQ2tu
A new Alleye study presented at #ARVO2024: Despite high digital exclusion risk, retinal patients using the Alleye app maintained strong outcomes, showing promise in the digital health age.
https://t.co/eMCRIDpSmC
#DigitalHealth#Telemedicine
Oculocare breaks new ground in the early detection of eye diseases. AlleyeOne can detect retinal diseases such as diabetic macular edema and age-related macular degeneration early via a digital test.
https://t.co/mjSvMANEpV
#healthcare#digitalhealth#mhealth#ophthalmology
Alleye, a mobile app to monitor eye diseases at home, is already in use in over 30 countries. This shows the increasing demand for telemedicine. Take a look at our new interactive map and find out, in which countries we operate : https://t.co/JK9EzErKs8
We are on the move – not only in our projects, but literally. As of March 1, you will find medignition, @AlleyeApp , Augenmobil and @CuraData at Engelstrasse. Enjoy the first sneak peek and stay tuned to see what the indoors look like, once we have unpacked!
A new study by a group of Swiss, British and US American researchers investigates the visual outcomes and treatment adherence of patients with macular pathology using a mobile hyperacuity home monitoring app. Read the results here: https://t.co/yJ4k4YPg1u
The ophthalmic research community continues to acknowledge Alleye’s contribution to the future of age-related macular degeneration (AMD) management.
#Alleye featured in the Asia-Pacific Journal of Ophthalmology: https://t.co/3GESqZ6HGO
#ophthalmology#digitalhealth
Very happy to announce our partnership with @Bayer in #Lebanon. We aim to utilize #digitalhealth to provide better eye care for local patients and support doctors through the launch of the #Alleye app.
https://t.co/kn0kqrLTQe
We are very proud to be part of this project. Thank you, @EyeCharity🙌 Looking forward to continue the inspiring collaboration with @dawnasim and @meriamsislam🤗
We are proud to support Associate Professor Dawn Sim @dawnasim with an innovation grant, to help fund research into the use of a self-test smartphone app for patients with macular oedema to monitor their vision from home.🏠📱 #MacularWeek
Find out more:👉 https://t.co/7gqI15uA6M
The new Alleye app – more than just a fresh coat of paint! We are excited to present our latest Alleye release: large font sizes, a modern color palette and a visual how-to.
https://t.co/EY8ErHsCai
#digitalhealth#ux#ui#vision#mhealth
Who uses a mobile app to monitor their eye diseases? Patients were more likely to use Alleye, if they...
– were younger (62 vs. 68 years)
– were not on treatment
– had poorer vision in their worse-seeing eye
https://t.co/fdfzMHWLcM
#digitalhealth#mhealth#clinicalresearch
How does the Singapore National Eye Centre use #Alleye to help patients self-monitor #eye diseases? An insightful interview with Dr Kelvin Teo.
https://t.co/dMbAZ8BeBq
#digitalhealth#telemedicine